Results 61 to 70 of about 8,335 (248)

Extensive morphea profunda with autoantibodies and benign tumors: A rare case report

open access: yesIndian Dermatology Online Journal, 2012
The term deep morphea describes a variant of morphea (localised scleroderma) in which inflammation and sclerosis are found in the deep dermis, panniculus, fascia or superficial muscle. It is sometimes associated with autoantibodies. We report the case of
Leelavathy Budamakuntla   +1 more
doaj   +1 more source

Prevalence and Clinical Characteristics of Systemic Sclerosis in Alaska Native and American Indian Peoples in Alaska

open access: yesACR Open Rheumatology, Volume 8, Issue 1, January 2026.
Objective Systemic sclerosis (SSc) is known to exhibit significant epidemiologic and clinical variation. This study aimed to describe the clinical and epidemiologic characteristics of SSc in Alaska Native and American Indian (AN/AI) individuals in Alaska.
Vivek R. Mehta   +5 more
wiley   +1 more source

Generalized morphea following radiotherapy for an intracranial tumor

open access: yesIndian Journal of Dermatology, 2016
Morphea is a localized scleroderma variety which can be circumscribed or generalized and is characterized by sclerotic plaques developing on trunk and limbs. Surgery and radiation have been implicated as etiological factors for the development of morphea.
Shrenik Balegar   +4 more
doaj   +1 more source

How I explore ... the skin functional involvement in scleroderma [PDF]

open access: yes, 2013
peer reviewedScleroderma refers to distinct clinical presentations sharing in common a sclerotic process most often clinically obvious on the skin. The involvement possibly affects the skin alone in morphea or in combination with internal lesions in ...
Andre, B.   +6 more
core  

Mapping the Tissue‐of‐Origins of Mesenchymal Stromal Cells in Injury Repair

open access: yesAdvanced Science, Volume 13, Issue 3, 14 January 2026.
This study maps mesenchymal stromal cells (MSCs) across multiple tissues, revealing that bone marrow–derived MSCs mobilize monocytes via CCL2 to promote systemic inflammation but do not migrate to distant organs to form fibrotic or tumor stroma. Instead, local MSCs dominate tissue remodeling, suggesting a “two‐hit” model linking systemic inflammation ...
Xinyu Thomas Tang   +4 more
wiley   +1 more source

Lokalisierte Sklerodermie (Morphea) im Kindesalter [PDF]

open access: yes, 2018
Zusammenfassung: Die lokalisierte (oder zirkumskripte) Sklerodermie (LS) oder Morphea ist eine sklerosierende Bindegewebserkrankung der Haut, die auch darunterliegende Gewebe wie Subkutis, Muskulatur und Skelett betreffen kann.
Weibel, L.
core  

Riociguat for the treatment of pulmonary arterial hypertension associated with connective tissue disease: results from PATENT-1 and PATENT-2 [PDF]

open access: yes, 2016
BACKGROUND: The 12-week, phase III Pulmonary Arterial hyperTENsion sGC-stimulator Trial (PATENT)-1 study investigated riociguat in patients with pulmonary arterial hypertension (PAH).
Boeckenhoff, A   +10 more
core   +1 more source

Moth‐Eaten Pattern of Alopecia in Lichen Planopilaris

open access: yesClinical Case Reports, Volume 14, Issue 1, January 2026.
ABSTRACT Moth‐eaten pattern of alopecia can be seen in various dermatological conditions, including lichen planopilaris (LPP). Clinical, trichoscopic, and histopathology correlation can give a clue to the etiology of moth‐eaten pattern of alopecia. Since alopecia in LPP is permanent, early recognition and treatment are necessary to prevent progression ...
Sunil Jaiswal   +3 more
wiley   +1 more source

Parry Romberg Syndrome with localized scleroderma: a case report [PDF]

open access: yes, 2014
Parry Romberg syndrome(PRS) is a rare acquired poorly understood neurocutaneous syndrome of unknown etiology characterized by slow progressive atrophic changes commonly affecting one half of the face. The exact incidence and etiology towards the syndrome
Gupta, Nikita   +3 more
core   +1 more source

Energy‐Based Devices for the Treatment of Cutaneous Lesions in Patients With Lupus Erythematosus and Dermatomyositis

open access: yesJournal of Cosmetic Dermatology, Volume 25, Issue 1, January 2026.
ABSTRACT Background The use of energy‐based devices (EBDs) for aesthetic and dermatological conditions is increasing, but data on efficacy and safety in autoimmune connective tissue disease (CTD) patients remain limited. Objectives This study assesses EBD real‐world treatment outcomes in Korean patients with lupus erythematosus (LE) and dermatomyositis
Hae Chang Joh   +2 more
wiley   +1 more source

Home - About - Disclaimer - Privacy